Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00234260 · ClinicalTrials.gov registry record
Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
NCT00234260: Clinical Trial study, sponsored by The University of Texas Health Science Center, Houston.
NCT00234260 is a clinical trial that was terminated before completion, run by The University of Texas Health Science Center, Houston. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00234260 was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
Study Summary
GENOA, the Genetic Epidemiology Network of Arteriopathy, consists of a network of three field centers and biochemical and genetic core labs to study the common polymorphic genetic variations to determine individual differences in blood pressure and essential hypertension in 1,500 sibling pairs in three racial groups. Linkage analyses are performed using an extensive array of candidate genes and anonymous markers throughout the genome.
Trial Details
| Field | Value |
|---|---|
| Start Date | 1995-04 |
Why NCT00234260 stopped before completion
NCT00234260 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00234260 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00234260 about?
NCT00234260 is a clinical study titled "Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)". GENOA, the Genetic Epidemiology Network of Arteriopathy, consists of a network of three field centers and biochemical and genetic core labs to study the common polymorphic genetic variations to determine individual differences in blood pressure and essential hypertension in 1,500 sibling pairs in th...
What is the current status of trial NCT00234260?
This trial is currently terminated. The study started on 1995-04.
Who is sponsoring clinical trial NCT00234260?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia